Hong Kong-listed dental aligner maker Angelalign Technology Inc. (06699) reported a marginal expansion in its share base for April 2026. The company issued 123,753 new ordinary shares under its Post-IPO Restricted Share Unit Scheme on 1 April, taking total issued shares (excluding treasury stock) to 170.90 million from 170.77 million a month earlier—an increase of 0.07 %.

Authorised capital remained unchanged at 500.00 million ordinary shares with a par value of USD 0.0001 each, equivalent to USD 50,000. Angelalign held no treasury shares during the month, and the public-float ratio continued to meet the exchange’s minimum requirement of 19.36 % of issued share capital.

Equity incentives showed limited activity. The Post-IPO Share Option Scheme ended April with 3.15 million outstanding options, while a further 4.52 million shares remain available for future grants. All options under the Pre-IPO Share Award Scheme III – Pool B have been fully exercised, and no shares were issued or transferred under the three Pre-IPO Share Award Schemes during the month.

No warrants, convertibles, or other share movements were recorded, and there were no changes to treasury share balances.